Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 401 - Irradiation products of cholesterol or its derivatives; Vitamin d derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
Patents for C07C 401 - Irradiation products of cholesterol or its derivatives; Vitamin d derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation (3,426)
02/2009
02/11/2009EP2021321A2 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof
02/11/2009EP2021320A2 2-substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin d analogs and uses thereof
01/2009
01/28/2009EP2018366A1 Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties
01/28/2009EP1768988B1 Novel phenyl-boronic acid derivatives and methods for the preparation thereof
01/27/2009CA2378803C Vitamin d3 analogs
01/15/2009WO2009008754A2 Process for the preparation of calcipotriol
01/15/2009WO2008131267A3 Low calcemic, highly antiproliferative, analogs of calcitriol
01/14/2009EP1466900B1 2-substituted vitamin d derivatives
01/13/2009CA2298944C Intermediates for synthesis of vitamin d
01/08/2009WO2007118198A8 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF
01/07/2009EP2011781A1 Process for production of indene derivative, and intermediate for production of the derivative
01/07/2009EP2010483A2 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and use thereof
01/06/2009CA2412541C 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-.beta.-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group
12/2008
12/31/2008WO2008023278A8 1alpha-hydroxy-2- (3 ' -hydroxypropylidene) -19-n0r- vitamin d compounds with a 1,1-dimethylpropyl side chain
12/25/2008US20080318911 20-Cyclopropyl, 26,27-Alkyl/Haloalkyl Vitamin D3 Compounds and Methods of Use Thereof
12/25/2008US20080317870 Compositions and Mehtods for Treating and Preventing Cancer Using Analogs of Vitamin D
12/24/2008WO2008128783A3 Photochemical process for the preparation of a previtamin d
12/24/2008EP2004597A2 1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds with a 1,1-dimethylpropyl side chain
12/23/2008US7468361 For therapy of skin conditions selected from the group consisting of dermatitis, eczema, keratosis, lack of skin firmness, wrinkles, lack of dermal hydration and insufficient sebum secretion
12/17/2008EP2001842A2 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof
12/17/2008EP2001841A2 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof
12/11/2008WO2008128782A3 Photochemical process for the preparation of a previtamin d
12/10/2008EP1809599B1 Vitamin d3 analogues for the prevention and treatment of bone disorders
12/10/2008CN101318988A Sterol extracted from crude glycerine and extracting method thereof
12/04/2008WO2008125901A3 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof
12/03/2008CN101316814A Method for producing vitamin D derivative utilizing photoreaction
12/03/2008CN101316813A Method for producing vitamin D derivative by using convergent method
11/2008
11/25/2008CA2276606C Method of treating prostatic diseases using active vitamin d analogues
11/18/2008CA2561590C Novel method for the preparation of intermediates useful for the synthesis of vitamin d analogues
11/13/2008US20080280859 Gemini vitamin d3 compounds and methods of use thereof
10/2008
10/30/2008WO2008131267A2 Low calcemic, highly antiproliferative, analogs of calcitriol
10/30/2008CA2684741A1 Low calcemic, highly antiproliferative, analogs of calcitriol
10/29/2008EP1984329A2 Vitamin d analog - rak, methods and uses thereof
10/29/2008CN101293894A 2-propylidene-19-nor-vitamin D compounds
10/22/2008EP1981843A2 Vitamin d analog: nel, methods and uses thereof
10/16/2008US20080255380 Process and Intermediates for the Preparation of Sulfonyl Derivatives of Cholecalciferol
10/15/2008EP1789384B1 Epimerisation of allylic alcohols
10/15/2008EP1453798B1 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
10/15/2008CN101287705A Synthesis of 1alpha-fluoro-25-hydroxy-16-23e-diene-26,27-bishomo-20-epi-cholecalciferol
10/09/2008WO2008091686A3 SYNTHESIS OF 1α-FLUORO-25-HYDROXY-16-23E-DIENE-26,27-BISHOMO-20-EPI-CHOLECALCIFEROL
10/09/2008WO2007092721A8 Vitamin d analog: rak, methods and uses thereof
10/01/2008CN100421667C Method for treating and preventing hyperparathyroidism
09/2008
09/23/2008CA2266479C Vitamin d analogues
09/17/2008CN101265225A Method for oxidizing unsaturated conjugated enol
09/09/2008CA2287881C Vitamin d3 analogs with bis c-20 side chains
08/2008
08/28/2008WO2007092720A8 Vitamin d analog: nel, methods and uses thereof
08/27/2008EP1961740A1 Method for producing vitamin d derivative utilizing photoreaction
08/13/2008EP1955999A1 Method for producing vitamin d derivative by using convergent method
08/07/2008US20080188548 Cyclic ether vitamin D3 compounds, 1alpha(OH)3-epi-vitamin D3 compounds and uses thereof
07/2008
07/31/2008WO2008091686A2 SYNTHESIS OF 1α-FLUORO-25-HYDROXY-16-23E-DIENE-26,27-BISHOMO-20-EPI-CHOLECALCIFEROL
07/31/2008CA2676512A1 Synthesis of 1.alpha.-fluoro-25-hydroxy-16-23e-diene-26,27-bishomo-20-epi-cholecalciferol
07/24/2008WO2008089093A2 Efficient processes for preparing steroids and vitamin d derivatives with the unnatural configuration at c20 (20 alpha-methyl) from pregnenolone
07/22/2008US7402688 novel 2,2-disubstituted-19-norvitamin D derivatives and 20-epi-19-norvitamin D derivatives; metabolic regulatory hormone of calcium and phosphorus; biological activities: cellular induced differentiation, suppression of proliferation, and immunomodulation by transcription control of target gene
07/17/2008WO2008023278A3 1alpha-hydroxy-2- (3 ' -hydroxypropylidene) -19-n0r- vitamin d compounds with a 1,1-dimethylpropyl side chain
07/17/2008US20080171728 Efficient Process for Preparing Steroids and Vitamin D Derivatives With the Unnatural Configuration at C20 (20 Alpha-Methyl) from Pregnenolone
07/16/2008EP1061070B1 Process for the preparation of ED-71
07/16/2008CN101223135A Preparation of paricalcitol and crystalline forms thereof
07/16/2008CN101220075A Preparation method for 7-dehydrochol esterol
07/16/2008CN100402497C Fluorinated vitamin D3 analogs
07/10/2008WO2007140380A3 Tagging reagents and methods for hydroxylated compounds
07/09/2008EP1940415A1 19,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin d3
07/03/2008US20080161587 Crystallization method for purification of calcipotriene
06/2008
06/25/2008EP1286962B1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds
06/19/2008WO2008035207A3 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof
06/11/2008CN101198336A 20-alkyl, gemini vitamin D3 compounds and methods of use thereof
06/05/2008WO2008035228A3 2- substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin d analogs and uses thereof
06/05/2008WO2008035206A3 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof
05/2008
05/29/2008WO2008061938A2 Method for the dehydrogenation of hydrocarbons, entailing dehydrogenation and oxidation steps
05/28/2008EP1924268A2 Synthesis of 1alpha-fluoro-25-hydroxy-16-23e-diene-26,27-bishomo-20-epi-cholecalciferol
05/22/2008WO2008039751A3 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs
05/21/2008EP1922303A2 Purification of paricalcitol
05/21/2008EP1265911B1 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents
05/08/2008WO2008053961A1 Process for production of 1-hydroxy-19-norcyclovitamin d derivative and intermediate for the production
05/08/2008CA2668544A1 Process for production of 1-hydroxy-19-norcyclovitamin d derivative and intermediate for the production
05/07/2008EP1688409B1 Vitamin d-derived monohalogenovinyl compounds
04/2008
04/17/2008DE102006047173B4 Verfahren zur Herstellung eines Analogons von Vitamin D Process for the preparation of an analogue of vitamin D
04/16/2008CN101163483A Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin d compounds or mimics thereof
04/03/2008WO2008039754A1 2-methylene-(20r,25s)-19,27-dinor-(22e)-vitamin d analogs
04/03/2008US20080081800 2-Methylene-(20R,25S)-19,27-Dinor-(22E)-Vitamin D Analogs
04/03/2008US20080081799 2-Methylene-(20S,25S)-19,27-Dinor-(22E)-Vitamin D Analogs
04/03/2008CA2662992A1 2-methylene-(20r,25s)-19,27-dinor-(22e)-vitamin d analogs
04/03/2008CA2662864A1 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs
04/01/2008US7351869 Solvent extraction using tetrahydrofuran amd methyl formate
03/2008
03/27/2008WO2008035228A2 2- substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin d analogs and uses thereof
03/27/2008CA2646911A1 2- substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin d analogs and uses thereof
03/27/2008CA2646909A1 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof
03/27/2008CA2645185A1 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof
03/26/2008EP1730108B1 Stereoselective synthesis of vitamin d analogues
03/18/2008CA2121689C 1.alpha.,24(s)-dihydroxy vitamin d2, its formation and use
03/13/2008US20080064668 Carbon 20 is substituted with methyl or cyclopropyl, carbon 16 is a single or double bond, and carbon 23 is a single, double, or triple bond; side effect reduction; vitamin deficiency; anticarcinogenic antiarthritic agents; immunotherapy; metabolic disorders; gene expression inhibition of ILT3
02/2008
02/28/2008CA2648521A1 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-n0r-vitamin d compounds with a 1,1-dimethylpropyl side chain
02/27/2008CN101130511A Polyhydroxy opened loop sterol, method for preparing the same and antineoplastic use of the same
02/14/2008WO2007131364A8 Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties
02/14/2008US20080039434 Treatment of Interstitial Cystitis with Vitamin D Compounds
02/07/2008US20080032956 2-Ethyl and 2-Ethylidene-19-Nor-Vitamin D Compounds
02/07/2008US20080032955 Vitamin d3 analogues for the prevention and treatment of bone disorders
02/06/2008EP1883626A2 LOW-CALCEMIC 16,23-DIENE 25-OXIME ANALOGS OF 1alpha,25-DIHYDROXY VITAMIN D3
02/05/2008CA2199893C 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives
01/2008
01/30/2008CN101115487A Prevention of thrombotic disorders with active vitamin d compounds or mimics thereof
01/30/2008CN100364970C Photochemical synthesis preparation method for vitamin D2
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 35